Glaxo (GSK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The global nicotine gums and mints market is projected to reach approximately USD 1,536.2 million by the end of 2024, with a ...
It has been about a month since the last earnings report for GSK (GSK). Shares have added about 8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...
Two conferences were held in Hanoi and Ho Chi Minh City in early March to discuss shingles in comorbid patients.
A ruling concerning a juicing machine, a tussle over a preliminary injunction and a new judge in Paris were among the top ...
The €150 million collaboration between UK pharma GSK and Germany’s CureVac builds on their existing relationship and will jointly develop next generation mRNA vaccines. It will attempt to ...
Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...
inventory building in the US and strong demand in Germany. GSK's HIV business, run through joint venture company ViiV Healthcare, also had a good quarter with sales up 14% to £1.4 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results